BioWorld

Jan. 15, 2010

BioInvent Plans to Raise $21M in Share Offering to Push Pipeline

Sweden's BioInvent International AB plans to raise SEK150 million (US$21M) by issuing 5.4 million new shares, money that could strengthen the company's position as it looks for new collaborations and opportunities to extend its pipeline. (BioWorld Today) Read More

FTC Chief, Democrats Seek to End Pay-for-Delay Generic Deals

Midbrain Serotonin Receptors Behind SSRI Treatment Failure?

NewCo News: Multiplatform Gliknik Tackling Cancer, Immune Disease Markets

Holiday Notice

Ride the Wave of Fortune Now; Pain for Health Care is Coming

CTI's $30M Offering Raises Eyebrows Ahead of Panel

Other News To Note

Clinic Roundup

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

Gene replacement rescues autism-related phenotypes in mice

BioWorld Science

Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...

For clonal hematopoiesis, epigenetics can be in driver’s seat

BioWorld Science

Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...

Illustration of amyloid plaques in Alzheimer's disease

Elixiron’s enrupatinib shows upbeat interim phase II AD results

BioWorld

Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...